[The TRACE Trial. Ten years after first publication of the results. (outlook from positions of 2007)].
Glezer
M G
MG
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003718:Denmark / Q000453:epidemiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009017:Morbidity / Q000639:trends; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D013318:Stroke Volume / Q000502:physiology; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D007211:Indoles; C052035:trandolapril